Generex shares soar on preliminary clinical results of oral spray insulin
8th Jul 2011, 12:00 pm by Deborah Sterescu Drug technology company Generex Biotechnology Corp (OTC: GNBT) rocketed more than 44% on Friday after the company announced extremely encouraging preliminary results from two phase 3 clinical trials testing the newest formulation of Generex Oral-lyn, designed as an oral, or spray meal-time insulin for diabetics. The first [...]